Q-omics provides the consensus-scored MIR3936 profile across patient tissues and cancer cell-line models. MIR3936 expression is associated with patient survival in 27 of 34 cancer types, with the highest sampling consensus in ACC. Among the 18 cancer types available for tumor–normal comparison, MIR3936 is differentially expressed in 11, with the highest sampling consensus in THCA. Additionally, MIR3936 RNA expression shows 18,616 significant gene co-expression associations, with the highest sampling consensus in UVM. Together, these results highlight ACC, THCA, and UVM as cancer lineages where MIR3936 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for MIR3936 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes MIR3936 survival associations across molecular data types. MIR3936 RNA expression shows survival associations in the most cancer types (27). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible MIR3936 RNA expression–survival associations across cancer types. High MIR3936 expression shows unfavorable associations in UCEC, but favorable associations in ACC, MESO, KIRP, PAAD and LGG. The ACC Kaplan–Meier curve shows clear separation, with the low-expression group declining faster, consistent with the favorable association (log-rank p < 0.001). Together, the overview and detailed table identify ACC as the clearest survival context for MIR3936 RNA expression.
This table summarizes MIR3936 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 11. The strongest signals are observed in THCA for RNA.
This table ranks reproducible tumor–normal expression differences for MIR3936. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. MIR3936 shows lower tumor expression in THCA, KICH, COAD, UCEC and LUSC and higher tumor expression in LIHC. The THCA box plot shows higher MIR3936 RNA expression in normal versus tumor tissue (log2 FC = −0.877, t-test p < 0.001).
This table shows molecular features associated with MIR3936 in patient tissues and cancer cell lines. In patient samples, MIR3936 shows the broadest associations at the RNA and protein expression levels, with UVM recurring as the lineage with the largest associated feature set.
